Dihydropyrimidine Dehydrogenase DeficiencySymptoms, Doctors, Treatments, Advances & More
Learn About Dihydropyrimidine Dehydrogenase Deficiency
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Umhc-Sylvester Comprehensive Cancer Center
Peter Hosein is a Hematologist practicing medicine in Miami, Florida. Dr. Hosein is rated as an Elite provider by MediFind in the treatment of Dihydropyrimidine Dehydrogenase Deficiency. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Dihydropyrimidine Dehydrogenase Deficiency, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy.
Olivier Capitain practices practicing medicine in Nantes, France. Mr. Capitain is rated as an Elite expert by MediFind in the treatment of Dihydropyrimidine Dehydrogenase Deficiency. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Dihydropyrimidine Dehydrogenase Deficiency, Head and Neck Squamous Cell Carcinoma (HNSCC), Colorectal Cancer, Anal Cancer, and Laryngectomy.
Joseph Ciccolini practices practicing medicine in Marseille, France. Mr. Ciccolini is rated as an Elite expert by MediFind in the treatment of Dihydropyrimidine Dehydrogenase Deficiency. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Dihydropyrimidine Dehydrogenase Deficiency, Breast Cancer, Lung Cancer, and Non-Small Cell Lung Cancer (NSCLC).
Summary: Doctors leading this study hope to find out if giving study participants' genetic information to cancer care providers will help personalize chemotherapy dosing decisions and decrease common chemotherapy side effects. Doctors leading the study will collect genetic information from study participants using pharmacogenomics/genotyping. Pharmacogenomics is the study of how the differences in our gene...
Summary: The goal of this clinical trial is to test the safety of the trifluridine/tipiracil as replacement of fluoropyrimidines based chemotherapy as first line metastatic colorectal or gastroesophageal cancer regimens in patients with dihydropyrimidine dehydrogenase (DPD) deficiency. The main questions it aims to answer are: * Is this alternative chemotherapy option a better option in term of safety for ...